AzTrials
AzTrials

Maternal DeathNCT02506413

Replicating MamaToto in Rural Tanzania

A study testing MamaToto Package in people with Maternal Death and Newborn Death, run by University of Calgary at 1 site in Tanzania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to adapt and implement a district-led, policy-based, low cost Maternal and Newborn Health (MNH) intervention package using the MamaToto process, proven successful in Uganda, in rural Tanzania. Read more about this study

Who is it for?
Ages 15 years and olderHealthy volunteers can take part
Conditions the study is for
Maternal Death, Newborn Death
What is being tested?
MamaToto Package
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8,323 participants
Where
1 siteTanzania
Study dates
Apr 2016to Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Randomly selected households (30) living in selected hamlets with a competent participant of greater than 15 years of age
  • All women of reproductive age (age 15-49 years old) living in selected households in selected hamlets

Who cannot join

  • Households with participants that are away for an extended time or have no one home at the time of survey completion

Trial locations and contacts

1 site in 1 country.

Tanzania1 site
  • Catholic University of Health and Allied Sciences

    Mwanza

Other trials in Tanzania

About this study

This study aimed to adapt and implement a district-led, policy-based, low cost Maternal and Newborn Health (MNH) intervention package using the MamaToto process, proven successful in Uganda, in rural Tanzania. The investigators hypothesized that the 'MamaToto Package' will be successfully implemented in the Misungwi District and will be effective in improving key maternal and newborn health indicators of study participants.

Read the detailed description

This study collected baseline data on indicators related to pre-natal care, delivery, post-natal care, treatment of childhood illnesses and family planning. Data collection tools/strategies included 1) a mapping exercise, 2) health facility audit 3) household surveys and 4) exit interviews. Data was collected at baseline and endline. Operational data was collected throughout the life of the study. Results were used to inform implementation of interventions that aim to improve health facility capacity to deliver good quality care to women and children and to strengthen families and communities to better advocate for and engage in activities that promote healthier women and children.

Mapping data was collected in two districts 1) Misungwi and 2) Kwimba. Baseline and endline data was collected in Misungwi only. The intervention began in Misungwi in Years 1 and 2 and then rolled out to Kwimba in Year 3.

Being tested
MamaToto Package
Keywords
Maternal and Newborn Health
Medical subject headings
Maternal Death, Perinatal Death

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MamaToto PackageOther

    Also called Mama na Mtoto

    The MamaToto Package (later called "Mama na Mtoto" for the Tanzanian context) was an MNCH intervention built upon prior successes in Uganda and adapted to meet the needs in Misungwi District in Tanzania. The intervention included low-cost programming that built upon the existing district health system structure and resources in order to strengthen the MNH capacity and training of the district, health facilities, and community health workers.

Study groups in NCT02506413
Study groupRoleWhat they receive
MNCH Intervention PackageOtherThe division assigned to this arm received a comprehensive Maternal and Newborn Health (MNH) intervention package using the 'MamaToto Process'. Key intervention activities included: 1. engaging district leaders in district health system strengthening; 2. strengthening health facility-based MNH services; and 3. establishing a Maternal, Newborn, and Child Health focused lay Community Health Worker program.
Receives: Other: MamaToto Package

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of live births attended by a skilled health provider

    Percentage of women (15-49 year old) with at least one recent live birth (past two years) reporting their last delivery being attended to by a skilled health personnel (doctor, nurse, midwife, clinical officer or auxiliary midwife)

    Measured: Change between pre (baseline) and post (endline-up to 36 months) intervention

Secondary outcomes (2)
  1. Proportion of women receiving postnatal care <48H

    Percentage of women (15-49 years old) with a recent birth (<2 years) reporting postnatal care by any provider for within 2 days (0-48 hours) after her most recent delivery.

    Measured: Change between pre (baseline) and post (endline-up to 36 months) intervention

  2. Proportion of women receiving antenatal care 4 or more times during pregnancy

    Percentage of women (15-49 years old) reporting four or more antenatal care visits at a health facility during their most pregnancy, where their last pregnancy was completed within two years of survey

    Measured: Change between pre (baseline) and post (endline-up to 36 months) intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2015 (estimated)
  2. Study startApr 2016
  3. Primary completionSep 2019
  4. Study completionMar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
This study was part of a longitudinal implementation evaluation using an effectiveness-intervention hybrid (Type 2) design and a RE-AIM evaluation model.
Masking
None (open label)
Enrolment
8,323 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02506413
Sponsor's protocol ID
IRT #39
Status last verified
Jul 2020
First submitted
1 Jul 2015
Last updated
9 Jul 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-Identified data will be shared with district officials, government offices and other stakeholders

Publications

  • Matovelo D, Boniphace M, Singhal N, Nettel-Aguirre A, Kabakyenga J, Turyakira E, Mercader HFG, Khan S, Shaban G, Kyomuhangi T, Hobbs AJ, Manalili K, Subi L, Hatfield J, Ngallaba S, Brenner JL. Evaluation of a comprehensive maternal newborn health intervention in rural Tanzania: single-arm pre-post coverage survey results. Glob Health Action. 2022 Dec 31;15(1):2137281. doi: 10.1080/16549716.2022.2137281.

    PubMed 36369729

Questions about this trial

What is this clinical trial studying?

A study testing MamaToto Package in people with Maternal Death and Newborn Death, run by University of Calgary at 1 site in Tanzania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tanzania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of live births attended by a skilled health provider (time frame: Change between pre (baseline) and post (endline-up to 36 months) intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02506413, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in